Axsome Therapeutics (AXSM) Receivables - Net (2022 - 2026)
Axsome Therapeutics (AXSM) reported Receivables - Net of $305.99 million for Q2 2026, up 40.0% from $218.64 million a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Receivables - Net (2022 - 2026) Analysis & Trends
At the end of FY2025, Axsome Therapeutics posted Receivables - Net of $246.67 million, up 58.6% from FY2024.
- Receivables - Net has increased for three consecutive years, with a three-year compound annual growth rate of 74.0% (FY2022 to FY2025).
- By year, Receivables - Net came in at $155.51 million in FY2024 (+44.9%), $107.32 million in FY2023 (+129.3%) and $46.8 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Receivables - Net in data going back to Q2 2022.
- Year over year, Receivables - Net has now increased in each of the last 13 quarters, with growth averaging 53.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Receivables - Net ran from 40.0% in Q2 2026 to 413.8% in Q2 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $273.19 million (Q1 2026), $246.67 million (Q4 2025) and $215.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Axsome Therapeutics | 9.64 Bn | 8.37 Bn | 204.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 305.99 Mn |
| Mar 31, 2026 | 273.19 Mn |
| Dec 31, 2025 | 246.67 Mn |
| Sep 30, 2025 | 215.85 Mn |
| Jun 30, 2025 | 218.64 Mn |
| Mar 31, 2025 | 176.18 Mn |
| Dec 31, 2024 | 155.51 Mn |
| Sep 30, 2024 | 138.40 Mn |
| Jun 30, 2024 | 133.53 Mn |
| Mar 31, 2024 | 115.12 Mn |
| Dec 31, 2023 | 107.32 Mn |
| Sep 30, 2023 | 88.39 Mn |
| Jun 30, 2023 | 83.06 Mn |
| Mar 31, 2023 | 57.81 Mn |
| Dec 31, 2022 | 46.80 Mn |
| Sep 30, 2022 | 20.30 Mn |
| Jun 30, 2022 | 16.17 Mn |
API Access
Axsome Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();